| Long covid—mechanisms, risk factors, and management H Crook, S Raza, J Nowell, M Young, P Edison bmj 374, 2021 | 1661 | 2021 |
| Covid-19: virology, variants, and vaccines M Young, H Crook, J Scott, P Edison BMJ medicine 1 (1), 2022 | 50 | 2022 |
| Long covid—mechanisms, risk factors, and management. bmj. 2021 Jul 26; 374 H Crook, S Raza, J Nowell, M Young, P Edison | 19 | |
| European working group on SARS-CoV-2: current understanding, unknowns, and recommendations on the neurological complications of COVID-19 H Crook, A Ramirez, A Hosseini, G Vavougyios, C Lehmann, J Bruchfeld, ... Brain connectivity 13 (4), 178-210, 2023 | 11 | 2023 |
| Multimodal analysis of the visual pathways in Friedreich's ataxia reveals novel biomarkers G Thomas‐Black, DR Altmann, H Crook, N Solanky, FP Carrasco, ... Movement Disorders 38 (6), 959-969, 2023 | 4 | 2023 |
| Longitudinal FDG‐PET and FTP‐PET demonstrates the relationship between glucose metabolism and tau accumulation in Alzheimer’s disease atrophy‐associated brain regions in … H Crook, J Nowell, S Raza, P Edison Alzheimer's & Dementia 17, e056276, 2021 | 2 | 2021 |
| Incretin mimetics as potential disease modifying treatment for Alzheimer’s disease H Crook, P Edison Journal of Alzheimer’s Disease 101 (s1), S357-S370, 2024 | | 2024 |
| CSF sTREM2 is associated with neuroprotective microglial states early in Alzheimer’s disease and deleterious effects later in the disease trajectory H Crook, M Wahdan, ME Tuil, NR Livingston, S Raza, J Nowell, P Edison Alzheimer's Association International Conference, 2024 | | 2024 |
| Regional microglial activation differs across the cortex of patients in the Alzheimer's disease trajectory: a cross-sectional study ME Tuil, V Calsolaro, H Crook, GD Femminella, G Pasqualetti, C Buckley, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Neuroinflammation and cognitive decline: a TSPO‐PET imaging study. H Crook, V Calsolaro, P Edison Alzheimer's & Dementia 19, e079874, 2023 | | 2023 |
| Elevated cerebrospinal fluid chitinase‐3 protein like‐1 (YKL‐40) is associated with decreased glucose metabolism in amyloid‐positive participants. FA Page, H Crook, P Edison Alzheimer's & Dementia 19, e079831, 2023 | | 2023 |
| Relationships between cerebral tau and glucose metabolism in cognitively normal older adults H Crook, J Debatisse, J Nowell, P Edison Alzheimer's & Dementia 19, e067754, 2023 | | 2023 |
| The dynamic functional role of triggering receptor expressed on myeloid cells 2 (TREM2) assessed with cerebrospinal fluid and positron emission tomography measures H Crook, M Wahdan, P Edison Alzheimer's & Dementia 19, e067792, 2023 | | 2023 |
| Increased pro‐inflammatory plasma markers are associated with a longitudinal decrease in left hippocampal volumes in MCI patients J Breese, J Nowell, H Crook, P Edison Alzheimer's & Dementia 18, e067093, 2022 | | 2022 |
| Influence of amyloid deposition on the interaction between tau and glucose metabolism J Nowell, S Raza, NR Livingston, H Crook, M Young, P Edison Alzheimer's & Dementia 17, e055974, 2021 | | 2021 |
| Does [18F] FDG and [18F] AV1451 PET predict neurodegeneration? J Nowell, M Young, S Raza, NR Livingston, H Crook, P Edison Alzheimer's & Dementia 17, e055950, 2021 | | 2021 |
